LEPR and thromboangiitis obliterans: Considering that the AUC for LEPR was >0.8 but that for THRB was <0.8, we selected LEPR as the key gene involved in the immunopathogenesis of TAO as well as a potential early‐warning biomarker and interventional target to prevent TAO in GD patients.